Anacor Pharmaceuticals Inc (ANAC)

HEALTH CARE: HEALTH CARE
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

1020 E. MEADOW CIRCLE PALO ALTO, CA 94303

Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing small-molecule therapeutics derived from its boron chemistry platform.

Are you looking for this stock instead?

View SEC Filings from ANAC instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ANAC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ANAC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GLAZER CAPITAL, LLC

GLAZER PAUL J

  • 10% Owner
2,968,202 2021-02-23 1

OCONNOR DAVID JUSTIN SEE REMARKS

  • Officer
  • Director
  • 10% Owner
0 2021-02-22 1

CHARLES IAN HUNTER

  • Director
  • 10% Owner
0 2021-02-22 1

EPSTEIN THEO NATHANIEL SEE REMARKS

  • Officer
  • Director
0 2021-02-22 1

VEDRO JOHN BARNEY CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-22 1

ARCTOS NORTHSTAR ACQUISITION HOLDINGS, LLC

  • 10% Owner
0 2021-02-22 1

SMITH JARED T

  • Director
0 2021-02-22 1

MCPHERRON MEREDITH LAZO

  • Director
0 2021-02-22 1

GUTIERREZ XAVIER A

  • Director
0 2021-02-22 1

COLLINS TOMAGO

  • Director
0 2021-02-22 1

SHAPIRO LUCY

  • Director
No longer subject to file 2016-06-24 0

HOVE ANDERS D

  • Director
No longer subject to file 2016-06-24 0

BERNS PAUL L PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2016-06-24 0

LESCHLY MARK

  • Director
No longer subject to file 2016-06-24 0

RIEFLIN WILLIAM JL

  • Director
No longer subject to file 2016-06-24 0

ZANE LEE SVP AND CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2016-06-24 0

IPPOLITO VINCENT P EVP & CHIEF COMMERCIAL OFFICER

  • Officer
No longer subject to file 2016-06-24 0

SULLIVAN RYAN T EVP AND GENERAL COUNSEL

  • Officer
No longer subject to file 2016-06-24 0

LEONARD KEITH R

  • Director
No longer subject to file 2016-06-24 0

WIERENGA WENDALL

  • Director
No longer subject to file 2016-06-24 0

BELL GRAEME EXECUTIVE VP AND CFO

  • Officer
No longer subject to file 2016-06-24 0

MAPLES KIRK R SVP, PROGRAM MANAGEMENT

  • Officer
7,220 2015-06-01 0

PLATTNER JACOB J SENIOR VP, RESEARCH

  • Officer
22,860 2015-05-15 0

RODRIGUEZ CARMEN R SNR VP REG AFRS & QUAL. ASSUR.

  • Officer
7,020 2015-05-12 0

PARKER GEOFFREY M. EXECUTIVE VICE PRESIDENT & CFO

  • Officer
277,840 2015-03-23 0

CHANDA SANJAY SVP, DRUG DEVELOPMENT

  • Officer
29,087 2015-03-04 0

KLINGENSTEIN PAUL H

  • Director
0 2014-05-29 0

PERRY DAVID P PRESIDENT AND CEO

  • Officer
  • Director
361,306 2014-03-04 0

RHO VENTURES IV QP LP

RHO VENTURES IV GMBH & CO BETEILIGUNGS KG

RHO VENTURES IV HOLDINGS LLC

RHO VENTURES IV LP

RHO MANAGEMENT VENTURES IV LLC

  • 10% Owner
No longer subject to file 2014-02-03 0

VENROCK ASSOCIATES IV L P

VENROCK PARTNERS, L.P.

VENROCK ENTREPRENEURS FUND IV L P

VENROCK MANAGEMENT IV, LLC

VENROCK PARTNERS MANAGEMENT, LLC

VEF MANAGEMENT IV, LLC

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VHCP CO-INVESTMENT HOLDINGS, LLC

VHCP MANAGEMENT, LLC

ROBERTS BRYAN E

  • 10% Owner
3,575,535 2013-11-15 0

RHO VENTURES IV LP

  • 10% Owner
243,815 2013-11-14 0

RHO VENTURES IV QP LP

RHO VENTURES IV HOLDINGS LLC

RHO VENTURES IV GMBH & CO BETEILIGUNGS KG

RHO VENTURES IV LP

RHO CAPITAL PARTNERS VERWALTUNGS GMBH

RHO MANAGEMENT VENTURES IV LLC

  • 10% Owner
4,371,423 2013-10-24 0

VENROCK ASSOCIATES V LP

VENROCK PARTNERS V L P

VENROCK MANAGEMENT V, LLC

VENROCK PARTNERS MANAGEMENT V, LLC

ROBERTS BRYAN E

  • 10% Owner
3,725,535 2012-09-20 0

VENROCK ASSOCIATES IV L P

VENROCK PARTNERS, L.P.

VENROCK ENTREPRENEURS FUND IV L P

VENROCK MANAGEMENT IV, LLC

VENROCK PARTNERS MANAGEMENT, LLC

VEF MANAGEMENT IV, LLC

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VHCP CO-INVESTMENT HOLDINGS, LLC

VHCP MANAGEMENT, LLC

  • 10% Owner
3,725,535 2012-09-20 0

HEYMAN IRWIN A SENIOR VP, DRUG DEVELOPMENT

  • Officer
0 2012-03-13 0

RHO MANAGEMENT TRUST I

  • 10% Owner
0 2011-12-20 0

RHO VENTURES IV HOLDINGS LLC

  • 10% Owner
1,533,600 2011-12-20 0

MARKHAM RICHARD J

  • Director
0 2011-05-25 0

RHO VENTURES IV QP LP

RHO VENTURES IV LP

RHO VENTURES IV GMBH & CO BETEILIGUNGS KG

RHO MANAGEMENT TRUST I

RHO CAPITAL PARTNERS VERWALTUNGS GMBH

RHO MANAGEMENT VENTURES IV LLC

RHO CAPITAL PARTNERS INC

KAIROUZ HABIB

RUCH JOSHUA

  • 10% Owner
5,621,423 2010-11-30 0

CARE CAPITAL INVESTMENTS II LP

CARE CAPITAL OFFSHORE INVESTMENTS II LP

  • 10% Owner
No longer subject to file 2010-11-30 0

VENROCK ASSOCIATES IV L P

VENROCK PARTNERS, L.P.

VENROCK ENTREPRENEURS FUND IV L P

VENROCK MANAGEMENT IV, LLC

VENROCK PARTNERS MANAGEMENT, LLC

VEF MANAGEMENT IV, LLC

  • 10% Owner
2,625,535 2010-11-30 0

ABERDARE VENTURES II, L.P.

ABERDARE VENTURES II (BERMUDA), L.P.

ABERDARE II ANNEX FUND L P

ABERDARE GP II, L.L.C.

  • 10% Owner
No longer subject to file 2010-11-30 0

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VHCP CO-INVESTMENT HOLDINGS, LLC

VHCP MANAGEMENT, LLC

ROBERTS BRYAN E

  • SEE FOOTNOTE 2SEE FOOTNOTE 2SEE FOOTNOTE 2SEE FOOTNOTE 2
2,000,000 2010-11-30 0

GLAXOSMITHKLINE PLC

  • 10% Owner
2,771,374 2010-11-24 0

HONG ZHI

  • Director
0 2010-11-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments